WTO uses AIDS patients to cover up development round failure
9 February 2006. Related: Treatment access.
Treatment access
Brazil’s deal with Abbott is challenged in courts
13 December 2005. Related: Treatment access.
Depletion of latent HIV-1 reservoir with valproic acid: interesting data but not a cure
13 October 2005. Related: Treatment access, Cure-related research, Basic science and immunology.
Does WHO clinical stage reliably predict who should receive ARV treatment?
14 September 2005. Related: Conference reports, Treatment access.
Continuous vs intermittent treatment with triple nuke combination of AZT/3TC/tenofovir in Africa: early results from DART study
14 September 2005. Related: Conference reports, Treatment access.
Global Fund commitment to $175M annually in 2006, 2007
14 September 2005. Related: Treatment access.
Forty injured, ten shot at peaceful protest to demand treatment in South Africa
14 August 2005. Related: Treatment access.
FDA approve additional Indian generics
14 August 2005. Related: Treatment access.
Medical innovation and patent gridlock
14 August 2005. Related: Treatment access.
Six Indian generic ARVs are given FDA tentative approval
14 July 2005. Related: Treatment access.
Methadone and buprenorphine added to WHO list of essential medicines
14 July 2005. Related: Treatment access.
MSF’s pricing guide to purchasing ARVs: 8th edition online
14 July 2005. Related: Treatment access.
WHO 3 by 5 progress report
14 July 2005. Related: Treatment access.
MSF criticises Brazilian government for failing to break antiretroviral patents
15 June 2005. Related: Treatment access.
Russian activists imprisoned for asking for treatment – letters of support requested
15 June 2005. Related: Treatment access.
Millions in Global Fund grants go unused: Indian government bureaucracies kill off people living with AIDS
15 May 2005. Related: Treatment access.
Demand for two originator ARVs could soon exceed supply
18 April 2005. Related: Treatment access.
Indian patent bill is introduced with no change: the beginning of the end of generics?
18 April 2005. Related: Treatment access.
Patent mailbox opened in India
18 April 2005. Related: Treatment access.
GSK calls on UK to use G8 presidency to enforce patents
18 April 2005. Related: Treatment access.
India admitted into Bush aid programme in same week that Indian parliament dismantles hope of future generic ARVs
18 April 2005. Related: Treatment access.
Community advocates meet with Indian generic companies: 2nd World CAB meeting
29 March 2005. Related: Treatment access.
AIDS activists concerned over drug prices post-patent
29 March 2005. Related: Treatment access.
India’s choice: editorial from NY Times
29 March 2005. Related: Treatment access.
Ranbaxy files three generic ARVs with US FDA
29 March 2005. Related: Treatment access.
FDA approves generic AZT/3TC/NVP fixed dose combination
29 March 2005. Related: Treatment access.
Treatment Access Campaign (TAC) awarded punitive costs in case against Minister of Health
29 March 2005. Related: Treatment access.
GSK grants license to Cipla in South Africa
29 March 2005. Related: Treatment access.
Generic ARVs and WHO prequalification list
29 January 2005. Related: Treatment access.
Cotrimoxazole reduces mortality and morbidity in HIV-positive children: joint WHO/UNAIDS/UNICEF statement
29 January 2005. Related: Treatment access.
Equitable access for antiretroviral treatment for women
29 January 2005. Related: Treatment access.
A round-up of news about access to treatments with links to sources: Britain, Ukraine, Thailand, Europe, South Africa
6 November 2004. Related: Treatment access.
Body Mass Index at diagnosis is independent predictor of survival
6 November 2004. Related: Treatment access.
Dollars, commerce, politics and prejudice all present obstacles to scaling up access to treatment in resource poor countries
6 September 2004. Related: Conference reports, Treatment access.
MTCT programmes in South Africa: nevirapine and the minister
6 September 2004. Related: Conference reports, Treatment access, Pregnancy.
Urgency of global access to ARV treatment for IV drug users
6 September 2004. Related: Conference reports, Treatment access, Injecting drug users.
Replace myths with evidence–based policies on IV drug use
6 September 2004. Related: Conference reports, Treatment access, Injecting drug users.
A round-up of news about access to treatments with links to sources
6 September 2004. Related: Treatment access.
Good generic drugs and good adherence in Rwanda
2 May 2004. Related: Conference reports, Treatment access, PK and drug interactions.
Outcomes after two years of providing antiretrovirals in Khayelitsha, South Africa
2 May 2004. Related: Treatment access.
A round-up of news on access to treatments
2 May 2004. Related: Treatment access.
Treatment with generics: tolerability, safety and resistance
5 April 2004. Related: Antiretrovirals, Treatment access.
International community meeting on drug pricing
2 April 2004. Related: Treatment access.
Global Fund halts $92 million grant for Ukraine after problems
2 April 2004. Related: Treatment access.
Global Fund says it needs $5 billion during 2004-2005
2 April 2004. Related: Treatment access.
South African minister of health in line to chair Global Fund
2 April 2004. Related: Treatment access.
Thai ddI patent case serves as example to other developing countries, Lancet viewpoint piece says
2 April 2004. Related: Treatment access.
UK gives £3 million to WHO’s ‘3 by 5’ treatment goal
2 April 2004. Related: Treatment access.
Global Fund awards bring total to $2.1bn and supply ARVs to 700,000 people
3 February 2004. Related: Treatment access.
Commentary: The Global Fund and treatment access in Latin America – a critical view
3 February 2004. Related: Treatment access.
Commentary: China starts long march against HIV
3 February 2004. Related: Treatment access.
WHO guidelines for use of ARVs in resource-poor settings
3 February 2004. Related: Treatment access.
Millions will benefit after GSK and BI license generic manufacturers to produce AZT, lamivudine and nevirapine
3 February 2004. Related: Treatment access.
Scaling up treatment access risks damaging national health systems, says WHO/UK report
3 February 2004. Related: Treatment access.
Access to treatment – some progress…
1 December 2003. Related: Treatment access.
WHO approves combination pills
1 December 2003. Related: Treatment access.
South African Competition Commission finds GSK and BI responsible for ‘excessive pricing’ and ‘abuse of market position’
1 December 2003. Related: Treatment access.
Access to HIV treatment in Eastern Europe
1 December 2003. Related: Treatment access.
Global AIDS spending must double by 2005, says gloomy UN
1 November 2003. Related: Treatment access.
GARPP requests permission from Boehringer to import generic nevirapine
1 November 2003. Related: Treatment access.
Canada decides to lead the way in exempting AIDS drugs from patent laws
1 November 2003. Related: Treatment access.
South Africa delays deregistering nevirapine
1 October 2003. Related: Treatment access.
Disagreement greets a new deal on patent protection and generic drugs for poor countries
1 October 2003. Related: Treatment access.
TRIPS agreement will not save lives
1 October 2003. Related: Treatment access.
Joint statement by 14 NGOs dismisses TRIPS deal as a ‘gift bound in red tape’
1 October 2003. Related: Treatment access.